Gerald Wayne Dryden1. 1. University of Louisville, Department of Medicine, Division of Gastroenterology, 550 South Jackson Street, Louisville, KY 40202, USA. tad.dryden@louisville.edu
Abstract
BACKGROUND: Crohn's disease (CD) therapy is rapidly evolving. Recent and ongoing clinical trials using immunologically active stem cells (SC) for the treatment of CD demonstrate the potential for this novel therapy to induce complete and long-lasting remission of symptoms in settings where 'standard' therapies have been unsuccessful. OBJECTIVE/ METHODS: This review of SC, including mesenchymal stem cell (MSC) therapy for CD discusses how the immunological effects of MSC may correct some of the pathophysiological defects underpinning CD, and examines the latest clinical trial data providing evidence of their efficacy in the treatment of Crohn's disease. RESULTS/ CONCLUSIONS: Given the beneficial effects on mucosal healing seen in animal models of inflammation and results from early clinical trials, MSC may serve as a candidate therapy for patients who have failed to respond to biological therapy.
BACKGROUND:Crohn's disease (CD) therapy is rapidly evolving. Recent and ongoing clinical trials using immunologically active stem cells (SC) for the treatment of CD demonstrate the potential for this novel therapy to induce complete and long-lasting remission of symptoms in settings where 'standard' therapies have been unsuccessful. OBJECTIVE/ METHODS: This review of SC, including mesenchymal stem cell (MSC) therapy for CD discusses how the immunological effects of MSC may correct some of the pathophysiological defects underpinning CD, and examines the latest clinical trial data providing evidence of their efficacy in the treatment of Crohn's disease. RESULTS/ CONCLUSIONS: Given the beneficial effects on mucosal healing seen in animal models of inflammation and results from early clinical trials, MSC may serve as a candidate therapy for patients who have failed to respond to biological therapy.
Authors: Brent R Weil; Mariuxi C Manukyan; Jeremy L Herrmann; Aaron M Abarbanell; Jeffrey A Poynter; Yue Wang; Daniel R Meldrum Journal: J Surg Res Date: 2010-08-06 Impact factor: 2.192
Authors: Andrea L DiCarlo; Radia Tamarat; Carmen I Rios; Marc Benderitter; Christine W Czarniecki; Theresa C Allio; Francesca Macchiarini; Bert W Maidment; Jean-Rene Jourdain Journal: Radiat Res Date: 2017-06-12 Impact factor: 2.841
Authors: Scott D Olson; Kari Pollock; Amal Kambal; Whitney Cary; Gaela-Marie Mitchell; Jeremy Tempkin; Heather Stewart; Jeannine McGee; Gerhard Bauer; Hyun Sook Kim; Teresa Tempkin; Vicki Wheelock; Geralyn Annett; Gary Dunbar; Jan A Nolta Journal: Mol Neurobiol Date: 2011-12-09 Impact factor: 5.590
Authors: Sabine Schu; Mikhail Nosov; Lisa O'Flynn; Georgina Shaw; Oliver Treacy; Frank Barry; Mary Murphy; Timothy O'Brien; Thomas Ritter Journal: J Cell Mol Med Date: 2012-09 Impact factor: 5.310